Clin2
NCT07768267Possibly a fitNot yet recruiting

Herbal supplement for bacterial overgrowth in irritable bowel syndrome

Irritable Bowel Syndrome (IBS)Small Intestinal Bacterial Overgrowth Syndrome (SIBO)

Part of Digestive system clinical trials.

This trial tests whether a herbal supplement called Biocidin REMOVE can help people with irritable bowel syndrome (IBS) who also have a condition called small intestinal bacterial overgrowth (SIBO), where too many bacteria grow in the small intestine. The study aims to see if the supplement can reduce symptoms and improve quality of life.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
40 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have been diagnosed with irritable bowel syndrome (IBS) and have had a breath test showing either high levels of hydrogen or methane (indicating bacterial overgrowth) or a 'flat line' pattern (very low gas levels).
  • If you are a woman who could become pregnant and are sexually active with a male partner, you must agree to use effective birth control.
  • You are not currently on a restricted diet (like low-carb, gluten-free, or low-FODMAP) and have not taken antibiotics or probiotics in the last 30 days.
  • You do not have other conditions like celiac disease, inflammatory bowel disease, liver disease, poorly controlled diabetes, or a weakened immune system.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07815548Not yet recruiting· Phase 4
Probiotic versus antibiotic for small intestinal bacterial overgrowth

This trial compares two treatments for SIBO, a condition that causes bloating and diarrhea due to too much bacteria in the small intestine. One treatment is a probiotic (a beneficial yeast) and the other is an antibiotic. The goal is to see which one works better.

Jinan, Shandong
NCT07426705Not yet recruiting· Phase 4
Probiotic supplement with rifaximin for irritable bowel syndrome

This study tests whether adding a probiotic supplement to the antibiotic rifaximin improves treatment for people with irritable bowel syndrome (IBS) and small intestinal bacterial overgrowth (SIBO), a condition where too many bacteria grow in the small intestine. If you have IBS and SIBO, this combination might help reduce your symptoms.

NCT07475299Not yet recruiting
Gut health supplement for irritable bowel syndrome

This study tests a daily supplement containing beneficial bacteria (synbiotic) and plant extracts to improve gut health and reduce symptoms of irritable bowel syndrome (IBS), such as bloating, gas, and changes in bowel habits. It lasts about 16 weeks and involves taking the supplement and providing blood and stool samples.

Cluj-Napoca
NCT07872514Enrolling by invitation
Personalized probiotics for irritable bowel syndrome

This study tests whether a probiotic treatment designed specifically for you can help ease your irritable bowel syndrome (IBS) symptoms. If you make it into the study, you'll get a treatment plan tailored to your gut and your symptoms.

Hamilton, Ontario
NCT06721884Recruiting· Phase 1/Phase 2
Artemisia annua for small intestinal bacterial overgrowth (SIBO)

This trial tests whether a supplement made from Artemisia annua (sweet wormwood) can help people with SIBO, a gut condition. You will take the supplement or a placebo for 5 weeks and have breath tests and blood draws to see how it affects your symptoms.

Portland, Oregon
NCT07584278Recruiting
Probiotics and Biomarkers for Irritable Bowel Syndrome

This study tests whether probiotics (beneficial bacteria) can help reduce irritable bowel syndrome (IBS) symptoms and change certain markers in your gut. You'll take a probiotic supplement for 12 weeks while researchers track how your symptoms and gut health change.

Gothenburg

Hear when a new Small Intestinal Bacterial Overgrowth Syndrome (SIBO) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.